Actively Recruiting
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
Led by Kaohsiung Medical University Chung-Ho Memorial Hospital · Updated on 2024-08-12
400
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
CONDITIONS
Official Title
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female over 20 years old, diagnosed with Parkinson's disease.
You will not qualify if you...
- People with Parkinson's disease Dementia, or Lactose Intolerance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kaohsiung Medical Univeristy Hospital
Kaohsiung City, Taiwan
Actively Recruiting
Research Team
Y
Yang-Pei Chang, M.D.; MSc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here